Guardant Health Inc
GH49.540USD
-0.960-1.90%
收盤 07/07, 16:00（美東）報價延遲15分鐘
6.13B總市值
虧損本益比TTM
關於 Guardant Health Inc 公司
Guardant Health, Inc. 是一家精準腫瘤學公司，致力於守護健康並讓每個人有更多時間遠離癌症。該公司通過先進的血液和組織測試、真實世界數據和人工智能 (AI) 分析，提供有關疾病驅動因素的關鍵見解。Guardant 測試有助於改善所有護理階段的結果，包括篩查以儘早發現癌症、監測早期癌症的復發以及幫助醫生爲晚期癌症患者選擇最佳治療方法。對於晚期癌症患者，該公司開發了 Guardant360 實驗室開發測試 (LDT) 和 Guardant360 CDx，這是一種全面的液體活檢測試，可爲實體腫瘤提供腫瘤突變分析，並可用作非小細胞肺癌 (NSCLC) 和乳腺癌的伴隨診斷。該公司還提供其他測試，包括 Guardant360 TissueNext 組織測試、Guardant Reveal 血液測試、Guardant360 Response 血液測試等。
公司簡介
公司代碼GH
公司名稱Guardant Health Inc
上市日期Oct 04, 2018
成立日期2011
CEODr. Amirali Talasaz, Ph.D.
員工數量1999
證券類型Ordinary Share
年結日Oct 04
公司地址3100 Hanover Street
城市PALO ALTO
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編94304
電話18556988887
網址https://guardanthealth.com/
公司代碼GH
上市日期Oct 04, 2018
成立日期2011
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Helmy A. Eltoukhy, Ph.D.
Dr. Helmy A. Eltoukhy, Ph.D.
Chairperson of the Board, Co-Chief Executive Officer
Chairperson of the Board, Co-Chief Executive Officer
2.75M
+0.43%
Dr. Amirali Talasaz, Ph.D.
Dr. Amirali Talasaz, Ph.D.
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
2.50M
-3.40%
Dr. Darya Chudova
Dr. Darya Chudova
Chief Technology Officer
Chief Technology Officer
80.44K
+1.88%
Mr. John Gomes Saia
Mr. John Gomes Saia
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
44.82K
+2.88%
Mr. Craig Eagle, M.D.
Mr. Craig Eagle, M.D.
Chief Medical Officer
Chief Medical Officer
36.79K
+4.75%
Ms. Vijaya V. Gadde
Ms. Vijaya V. Gadde
Independent Director
Independent Director
24.31K
+37.83%
Ms. Myrtle Stephens Potter
Ms. Myrtle Stephens Potter
Independent Director
Independent Director
18.15K
+29.09%
Mr. Kumud Kalia
Mr. Kumud Kalia
Chief Information Officer
Chief Information Officer
17.82K
+8.04%
Ms. Meghan V. Joyce
Ms. Meghan V. Joyce
Independent Director
Independent Director
11.15K
+42.11%
Mr. Musa Tariq
Mr. Musa Tariq
Independent Director
Independent Director
7.19K
+106.67%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Helmy A. Eltoukhy, Ph.D.
Dr. Helmy A. Eltoukhy, Ph.D.
Chairperson of the Board, Co-Chief Executive Officer
Chairperson of the Board, Co-Chief Executive Officer
2.75M
+0.43%
Dr. Amirali Talasaz, Ph.D.
Dr. Amirali Talasaz, Ph.D.
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
2.50M
-3.40%
Dr. Darya Chudova
Dr. Darya Chudova
Chief Technology Officer
Chief Technology Officer
80.44K
+1.88%
Mr. John Gomes Saia
Mr. John Gomes Saia
Chief Legal Officer, Corporate Secretary
Chief Legal Officer, Corporate Secretary
44.82K
+2.88%
Mr. Craig Eagle, M.D.
Mr. Craig Eagle, M.D.
Chief Medical Officer
Chief Medical Officer
36.79K
+4.75%
Ms. Vijaya V. Gadde
Ms. Vijaya V. Gadde
Independent Director
Independent Director
24.31K
+37.83%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Oncology
150.56M
74.00%
Biopharma and data
45.38M
22.30%
Screening
5.68M
2.79%
Licensing and other
1.86M
0.91%
地區USD
名稱
營收
佔比
United States
193.61M
95.15%
International
9.86M
4.85%
業務
地區
業務USD
名稱
營收
佔比
Oncology
150.56M
74.00%
Biopharma and data
45.38M
22.30%
Screening
5.68M
2.79%
Licensing and other
1.86M
0.91%
股東統計
更新時間: 6月21日 週六
更新時間: 6月21日 週六
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
9.73%
BlackRock Institutional Trust Company, N.A.
6.95%
Deep Track Capital LP
4.39%
Capital International Investors
4.16%
Baillie Gifford & Co.
4.09%
Other
70.69%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
9.73%
BlackRock Institutional Trust Company, N.A.
6.95%
Deep Track Capital LP
4.39%
Capital International Investors
4.16%
Baillie Gifford & Co.
4.09%
Other
70.69%
股東類型
持股股東
佔比
Investment Advisor
38.09%
Investment Advisor/Hedge Fund
33.25%
Hedge Fund
21.67%
Individual Investor
4.57%
Research Firm
2.22%
Bank and Trust
1.82%
Sovereign Wealth Fund
1.81%
Pension Fund
1.28%
Insurance Company
0.03%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
741
129.90M
104.85%
-16.16M
2025Q1
783
130.34M
105.23%
-16.59M
2024Q4
746
130.16M
105.47%
-20.09M
2024Q3
780
137.29M
111.53%
-9.70M
2024Q2
801
127.50M
103.74%
-18.45M
2024Q1
826
124.00M
101.88%
-12.71M
2023Q4
856
120.18M
99.30%
-14.26M
2023Q3
867
117.78M
100.31%
-19.15M
2023Q2
890
119.83M
102.55%
+840.96K
2023Q1
908
101.46M
98.78%
-16.37M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
12.05M
9.73%
+28.83K
+0.24%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
8.61M
6.95%
-284.70K
-3.20%
Mar 31, 2025
Deep Track Capital LP
5.44M
4.39%
-975.85K
-15.20%
Mar 31, 2025
Capital International Investors
5.15M
4.16%
+674.48K
+15.08%
Mar 31, 2025
Baillie Gifford & Co.
5.06M
4.09%
-388.09K
-7.12%
Mar 31, 2025
Cadian Capital Management LP
4.60M
3.71%
-626.48K
-12.00%
Mar 31, 2025
Two Sigma Investments, LP
4.19M
3.38%
-12.65K
-0.30%
Mar 31, 2025
Citadel Advisors LLC
3.60M
2.9%
+2.12M
+142.72%
Mar 31, 2025
Eventide Asset Management, LLC
3.57M
2.88%
-241.20K
-6.33%
Mar 31, 2025
Capital Research Global Investors
2.93M
2.37%
+190.45K
+6.95%
Mar 31, 2025
查看更多
持股ETF
更新時間: 7月6日 週日
更新時間: 7月6日 週日
機構名稱
佔比
ARK Genomic Revolution ETF
6.11%
Global X Genomics & Biotechnology ETF
3.8%
Invesco Dorsey Wright Healthcare Momentum ETF
3.24%
Franklin Genomic Advancements ETF
2.43%
First Trust Nasdaq Lux Digi Health Solutions ETF
2.21%
ROBO Global Healthcare Technology & Innovation ETF
2.12%
Alger Mid Cap 40 ETF
1.85%
SPDR S&P Health Care Services ETF
1.82%
BNY Mellon Innovators ETF
1.39%
iShares Health Innovation Active ETF
1.23%
查看更多
ARK Genomic Revolution ETF
佔比6.11%
Global X Genomics & Biotechnology ETF
佔比3.8%
Invesco Dorsey Wright Healthcare Momentum ETF
佔比3.24%
Franklin Genomic Advancements ETF
佔比2.43%
First Trust Nasdaq Lux Digi Health Solutions ETF
佔比2.21%
ROBO Global Healthcare Technology & Innovation ETF
佔比2.12%
Alger Mid Cap 40 ETF
佔比1.85%
SPDR S&P Health Care Services ETF
佔比1.82%
BNY Mellon Innovators ETF
佔比1.39%
iShares Health Innovation Active ETF
佔比1.23%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
